Replies to post #35497 on MMRGlobal, Inc. (fka MMRF)

[markgovols]

Wow. Now this is good stuff. MEAT and POTATOES!!!!

[EZ2]

The Company is also in the process of forming a separate operating subsidiary to maximize the value of its intellectual property, specifically its biotech assets which the Company believes may have significant commercial value. These assets include its Anti-CD20 antibody which the Company believes to be a first cousin to Rituximab. Rituximab is scheduled to go off patent in 2015 and currently represents over 6.6 billion dollars in annual sales.